300267 尔康制药
2025/06 - 中期
人民币(K¥)
与去年末期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)

非流动资产
长期股权投资71,738-0.00%71,740120,229138,968146,158
投资性房地产76,480-2.05%78,08381,28885,26388,656
固定资产2,329,876-2.31%2,384,9732,577,8322,681,7091,983,721
在建工程193,49810.84%174,575220,89052,917506,179
无形资产353,853-2.67%363,556378,034406,136431,447
商誉2,0030.00%2,0032,00310,00810,008
其他非流动资产406,444-0.31%407,723367,778389,666319,445
3,433,892-1.40%3,482,6533,748,0553,764,6683,485,614

流动资产
货币资金492,516-29.49%698,538744,350764,669761,564
应收账款162,70357.69%103,182109,154133,693186,496
存货625,3894.10%600,779691,603821,345714,772
其他流动资产335,3916.61%314,583185,907371,497283,533
1,615,999-5.89%1,717,0821,731,0142,091,2041,946,365

流动负债
短期借款310,083-36.48%488,198341,889396,641246,000
应付票据0--0000
应付帐款130,88014.15%114,656122,299198,705137,871
其他流动负债92,906-9.35%102,487139,113130,087115,056
533,868-24.31%705,342603,301725,433498,926
流动资产净值1,082,1316.96%1,011,7401,127,7131,365,7711,447,439
资产总额减流动负债4,516,0230.48%4,494,3924,875,7685,130,4394,933,053

非流动负债
长期借款0--0000
应付债券0--0000
其他非流动负债100,5759.08%92,19965,75479,13559,351
100,5759.08%92,19965,75479,13559,351

总权益
    实收股本2,062,6050.00%2,062,6052,062,6052,062,6052,062,605
    储备项目2,406,9360.93%2,384,8212,773,4412,988,4262,788,607
股东权益4,469,5410.50%4,447,4264,836,0465,051,0314,851,211
非控股权益(54,093)19.59%(45,232)(26,032)27322,490